RecruitingNCT01432847
Ophthalmological
Best vitelliform macular dystrophy
5
studies recruiting now
as of 7 Sept 2026
10
studies registered in total
as of 7 Sept 2026
3
countries with a recruiting site
as of 7 Sept 2026
22 Sept 2025
most recent study posted
among recruiting studies
Recruiting trials
RecruitingNCT06491615
National Ophthalmic Genotyping and Phenotyping Network (eyeGENE (Registered Trademark)), Stage 3 - Expansion of DNA and Data Repositories for Rare Inherited Ophthalmic Diseases
RecruitingNCT02435940
Inherited Retinal Degenerative Disease Registry
RecruitingPhase 1 / Phase 2NCT07185256
Safety and Tolerability of Subretinally Injected OPGx-BEST1 in Patients With Best Vitelliform Macular Dystrophy (BVMD) or Autosomal-Recessive Bestrophinopathy (ARB)
RecruitingNCT05809635
Study of BEST1 Vitelliform Macular Dystrophy
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
Search all Best vitelliform macular dystrophy studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Best vitelliform macular dystrophy study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Best vitelliform macular dystrophy
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations, and the gene involved (BEST1).
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).